Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity
Main Authors: | Dilvin Semo, Holger Reinecke, Rinesh Godfrey |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-02-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-024-01746-y |
Similar Items
-
Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function
by: Marc Dorenkamp, et al.
Published: (2023-02-01) -
Gut microbiome: Role in insulin resistance in obstructive sleep apnea
by: Allan I. Pack
Published: (2021-03-01) -
The identification of a novel shared therapeutic target and drug across all insulin-sensitive tissues under insulin resistance
by: Jinyuan Xu, et al.
Published: (2024-03-01) -
Exposure to environmental toxicants is associated with gut microbiome dysbiosis, insulin resistance and obesity
by: Partho Sen, et al.
Published: (2024-04-01) -
Composition and Functions of the Gut Microbiome in Pediatric Obesity: Relationships with Markers of Insulin Resistance
by: Camila E. Orsso, et al.
Published: (2021-07-01)